MELISSA LEMNAH: Open Payments
NPI 1144658014 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 42 payments from 17 companies in 2025. Trend: 2023 $1,504 · 2024 $1,134 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $199 |
| Boston Scientific Corporation | 3 | $144 |
| UROGEN PHARMA, INC. | 3 | $112 |
| Endo USA, Inc. | 5 | $101 |
| ACCORD HEALTHCARE, INC. | 3 | $73 |
| PFIZER INC. | 2 | $71 |
| Antares Pharma, Inc. | 2 | $53 |
| Ferring Pharmaceuticals Inc. | 3 | $51 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $48 |
| TOLMAR, INC. | 2 | $45 |
Products named: JELMYTO, Axonics, ORGOVYX, GEMTESA, Camcevi, XTANDI, XYOSTED, XIAFLEX.
Industry payments across NC — which companies pay providers there.
